Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone Rhinosinusitis Efficacy Trial (PRET)
2008-000560-17Phase 3Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Aug 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute rhinosinusitis (ARS) comparing Prednisolone 30 mg daily with Placebo daily (2 arms). Primary endpoint: Resolution of facial pain at day 7. Started Aug 2008; status: completed.
02
Drugs
prednisolone
03
Conditions
acute rhinosinusitis (ARS)
Beyond the preview
Go deeper on 2008-000560-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000560-17.